Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,672 | 523 | 96.5% |
| Education | $350.69 | 5 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,193 | 179 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,013 | 77 | $0 (2022) |
| Nevro Corp. | $906.43 | 9 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $796.66 | 55 | $0 (2024) |
| Lilly USA, LLC | $668.95 | 43 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $629.98 | 22 | $0 (2024) |
| Medtronic, Inc. | $384.95 | 3 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $373.55 | 15 | $0 (2022) |
| Astellas Pharma US Inc | $361.68 | 6 | $0 (2019) |
| Merck Sharp & Dohme LLC | $306.47 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $960.36 | 41 | AstraZeneca Pharmaceuticals LP ($317.23) |
| 2023 | $557.81 | 23 | Nevro Corp. ($171.31) |
| 2022 | $1,380 | 65 | Nevro Corp. ($534.10) |
| 2021 | $1,533 | 75 | Novo Nordisk Inc ($509.72) |
| 2020 | $1,260 | 72 | Novo Nordisk Inc ($623.71) |
| 2019 | $1,795 | 132 | Novo Nordisk Inc ($448.98) |
| 2018 | $933.66 | 57 | Astellas Pharma US Inc ($262.68) |
| 2017 | $1,603 | 63 | Janssen Pharmaceuticals, Inc ($388.87) |
All Payment Transactions
528 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.40 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Neuropsychiatry | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Cardio-renal | ||||||
| 09/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Neurology | ||||||
| 08/20/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $16.98 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Oncology | ||||||
| 08/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: RESPIRATORY | ||||||
| 07/30/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Neurology | ||||||
| 07/25/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: RESPIRATORY | ||||||
| 06/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: Respiratory | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 993 | 2,573 | $392,762 | $148,998 |
| 2022 | 20 | 1,186 | 2,773 | $410,004 | $159,124 |
| 2021 | 20 | 1,223 | 3,033 | $434,406 | $230,183 |
| 2020 | 23 | 1,361 | 2,718 | $400,832 | $188,069 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 319 | 1,202 | $216,360 | $74,372 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 257 | 257 | $44,975 | $20,485 | 45.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 167 | 319 | $39,875 | $17,465 | 43.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 25 | 223 | $22,300 | $9,520 | 42.7% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 57 | 254 | $25,400 | $8,601 | 33.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 16 | 110 | $11,000 | $5,168 | 47.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $4,352 | $2,395 | 55.0% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 31 | 32 | $5,920 | $2,253 | 38.1% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 18 | 45 | $2,925 | $1,581 | 54.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 35 | $3,150 | $1,495 | 47.5% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 16 | 17 | $3,145 | $1,494 | 47.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 13 | $5,200 | $1,478 | 28.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $4,370 | $1,136 | 26.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $2,750 | $944.33 | 34.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 13 | 16 | $1,040 | $610.06 | 58.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 317 | 1,025 | $184,500 | $66,842 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 213 | 463 | $57,875 | $23,464 | 40.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 194 | 194 | $33,950 | $14,546 | 42.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 33 | 234 | $23,400 | $10,080 | 43.1% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 47 | 248 | $24,800 | $9,178 | 37.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 26 | 167 | $16,700 | $8,425 | 50.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 26 | 31 | $12,400 | $3,442 | 27.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 40 | 40 | $7,490 | $3,026 | 40.4% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 34 | 44 | $8,140 | $3,013 | 37.0% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Facility | 2022 | 24 | 34 | $6,290 | $2,613 | 41.5% |
About Dr. Ketankumar Vaidya, MD
Dr. Ketankumar Vaidya, MD is a Geriatric Medicine healthcare provider based in Edison, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487688586.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ketankumar Vaidya, MD has received a total of $10,023 in payments from pharmaceutical and medical device companies, with $960.36 received in 2024. These payments were reported across 528 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($9,672).
As a Medicare-enrolled provider, Vaidya has provided services to 4,763 Medicare beneficiaries, totaling 11,097 services with total Medicare billing of $726,373. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Practice Information
- Specialty Geriatric Medicine
- Location Edison, NJ
- Active Since 07/11/2006
- Last Updated 03/28/2023
- Taxonomy Code 207RG0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487688586
Products in Payments
- Ozempic (Drug) $1,457
- XARELTO (Drug) $865.56
- Omnia (Device) $735.12
- ENTRESTO (Drug) $500.95
- TRULICITY (Drug) $418.62
- JARDIANCE (Drug) $308.09
- Kerendia (Drug) $304.31
- LEQVIO (Drug) $295.71
- Rybelsus (Drug) $197.87
- INTELLIS (Device) $197.45
- CoreValve Evolut (Device) $187.50
- LOKELMA (Drug) $187.37
- RYBELSUS (Drug) $184.45
- JANUVIA (Drug) $183.19
- FARXIGA (Drug) $178.15
- Senza (Device) $171.31
- TRELEGY ELLIPTA (Drug) $167.92
- INVOKANA (Drug) $147.06
- BREZTRI (Drug) $139.50
- SOLIQUA 100/33 (Drug) $136.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in Edison
Dr. Richard Bullock, Md, MD
Geriatric Medicine — Payments: $7,343
Mrs. Bhavana Rebba, M.d, M.D
Geriatric Medicine — Payments: $2,486
Dr. Pankaj Gupta, Md, Mba, MD, MBA
Geriatric Medicine — Payments: $1,534
Zareen Syed, Md, MD
Geriatric Medicine — Payments: $942.69
Dr. Joy-Lynne Carnes, Md, MD
Geriatric Medicine
Elizabeth Collins, M.d, M.D
Geriatric Medicine